Ligand validation:2EVU

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2EVU_GOL_A_502	30%	89%	0.235	0.902	0.2	0.44	-	-	0	0	100%	1
2EVU_GOL_A_504	27%	91%	0.165	0.813	0.14	0.43	-	-	1	0	100%	1
2EVU_GOL_A_501	20%	90%	0.276	0.881	0.21	0.4	-	-	3	0	100%	1
2EVU_GOL_A_503	18%	90%	0.264	0.849	0.11	0.5	-	-	2	0	100%	1
2EVU_GOL_A_500	2%	90%	0.451	0.694	0.22	0.39	-	-	0	0	100%	1
2EVU_GOL_A_505	1%	90%	0.336	0.51	0.14	0.46	-	-	0	0	100%	1
2F2B_GOL_A_501	21%	0%	0.188	0.796	4.56	5.84	5	3	0	0	100%	1
1SSX_GOL_A_249	100%	72%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	41%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.